Primary sternum diffuse large B‑cell lymphoma: A case report and review of the literature Corrigendum in /10.3892/ol.2021.12453

Tong,Meng‑Ying; Zhang,Xian; Yu,Zhe; Sun,Xiu‑Hua; Li,Shuang; Zhang,Yang

doi:10.3892/ol.2015.3122

Primary sternum diffuse large B‑cell lymphoma: A case report and review of the literature

Corrigendum in: /10.3892/ol.2021.12453

Authors:
- Meng‑Ying Tong
- Xian Zhang
- Zhe Yu
- Xiu‑Hua Sun
- Shuang Li
- Yang Zhang
View Affiliations

Affiliations: Graduate Institute of Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Department of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, P.R. China
Published online on: April 16, 2015 https://doi.org/10.3892/ol.2015.3122
Pages: 2623-2628

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Primary bone lymphoma (PBL) is a rare disease, accounting for >1% of all cases of malignant lymphoma. Diffuse large B‑cell lymphoma (DLBCL) is the most common histological type of PBL. The present study reported the case of a 68‑year‑old male with primary bone DLBCL, originally occurred in the sternum, which is a rare form of presentation. Computed tomography (CT), magnetic resonance imaging and bone emission CT were performed, followed by immunohistochemical analysis of a biopsy specimen, and the results were used to establish the diagnosis. At the time of diagnosis, no osseous involvement was observed. The clinical, radiological and histological features of PBL can mimic other medical conditions, thereby making the diagnosis difficult, and frequently leading to delays in treatment. The present study investigated the clinical features, management and prognosis of PBL, and reviewed previous relevant cases.

View Figures

View References

1	Ford DR, Wilson D, Sothi S, Grimer R and Spooner D: Primary bone lymphoma - treatment and outcome. Clin Oncol (R Coll Radiol). 19:50–55. 2007. View Article : Google Scholar : PubMed/NCBI
2	Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD and Connors JM: A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 18:129–135. 2007. View Article : Google Scholar : PubMed/NCBI
3	Krishnan A, Shirkhoda A, Tehranzadeh J, et al: Primary bone lymphoma: Radiographic-MR imaging correlation. Radiographics. 23:1371–1387; discussion 1384–1387. 2003. View Article : Google Scholar : PubMed/NCBI
4	Mengiardi B, Honegger H, Hodler J, et al: Primary lymphoma of bone: MRI and CT characteristics during and after successful treatment. Am J Roentgenol. 184:185–192. 2005. View Article : Google Scholar
5	Glotzbecker MP, Kersun LS, Choi JK, et al: Primary non-Hodgkin's lymphoma of bone in children. J Bone Joint Surg Am. 88:583–594. 2006. View Article : Google Scholar : PubMed/NCBI
6	Lister TA, Crowther D, Sutcliffe SB, et al: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 7:1630–1636. 1989.PubMed/NCBI
7	Reddy N and Greer JP: Primary bone lymphoma: A set of unique problems in management. Leuk Lymphoma. 51:1–2. 2010. View Article : Google Scholar : PubMed/NCBI
8	Zhao XF, Young KH, Frank D, et al: Pediatric primary bone lymphoma - diffuse large B-cell lymphoma: Morphologic and immunohistochemical characteristics of 10 cases. Am J Clin Pathol. 127:47–54. 2007. View Article : Google Scholar : PubMed/NCBI
9	Bruno Ventre M, Ferreri AJ, Gospodarowicz M, et al: International Extranodal Lymphoma Study Group: Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist. 19:291–298. 2014. View Article : Google Scholar : PubMed/NCBI
10	Beal K, Allen L and Yahalom J: Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer. 106:2652–2656. 2006. View Article : Google Scholar : PubMed/NCBI
11	No authors listed: A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 329:987–994. 1993. View Article : Google Scholar : PubMed/NCBI
12	Cheson BD, Horning SJ, Coiffier B, et al: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. NCI Sponsored International Working Group. J Clin Oncol. 17:12441999.PubMed/NCBI
13	Langley CR, Garrett SJ, Urand J, Kohler J and Clarke NM: Primary multifocal osseous Hodgkin's lymphoma. World J Surg Oncol. 6:342008. View Article : Google Scholar : PubMed/NCBI
14	Gupta A, Kataria SP, Kumar K and Subramanian S: Primary non Hodgkin's lymphoma of sternum. Indian J Med Paediatr Oncol. 27:282006.
15	Levitt LJ, Aisenberg AC, Harris NL, et al: Primary non-Hodgkin's lymphoma of the mediastinum. Cancer. 50:2486–2492. 1982. View Article : Google Scholar : PubMed/NCBI
16	Kabiri el H, Kabiri M and Doghmi K: Primary non-Hodgkin lymphoma of the sternum. Arch Bronconeumol. 45:259–260. 2009.(In Spanish). View Article : Google Scholar : PubMed/NCBI
17	Maslovsky I and Gefel D: Hodgkin's disease. Haematologica. 90 (12 Suppl):EIM022005.PubMed/NCBI
18	Graziadio M, Medina N, Amato M, et al: Primary bone lymphoma with multicentric involvement. Medicina (B Aires). 72:4284302012.(In Spanish). PubMed/NCBI
19	Heyning FH, Hogendoorn PC, Kramer MH, et al: Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia. 13:2094–2098. 1999. View Article : Google Scholar : PubMed/NCBI
20	Demircay E, Hornicek FJ Jr, Mankin HJ and Degroot H III: Malignant lymphoma of bone: a review of 119 patients. Clin Orthop Relat Res. 471:2684–2690. 2013. View Article : Google Scholar : PubMed/NCBI
21	Dubey P, Ha CS, Besa PC, et al: Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys. 37:1087–1093. 1997. View Article : Google Scholar : PubMed/NCBI
22	Mikhaeel NG: Primary bone lymphoma. Clin Oncol (R Coll Radiol). 24:366–370. 2012. View Article : Google Scholar : PubMed/NCBI
23	Moog F, Kotzerke J and Reske SN: FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med. 40:1407–1413. 1999.PubMed/NCBI
24	Park YH, Kim S, Choi SJ, et al: Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone. Ann Oncol. 16:1401–1402. 2005. View Article : Google Scholar : PubMed/NCBI
25	Ng AK and Mauch PM: Role of radiation therapy in localized aggressive lymphoma. J Clin Oncol. 25:757–759. 2007. View Article : Google Scholar : PubMed/NCBI
26	Bonnet C, Fillet G, Mounier N, et al: Groupe d'Etude des Lymphomes de l'Adulte: CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 25:787–792. 2007. View Article : Google Scholar : PubMed/NCBI
27	Reyes F, Lepage E, Ganem G, et al: Groupe d'Etude des Lymphomes de l'Adulte (GELA): ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 352:1197–1205. 2005. View Article : Google Scholar : PubMed/NCBI
28	Beal K, Allen L and Yahalom J: Excellent long-term experience with primary bone lymphoma: Analysis of prognostic factors. J Clin Oncol. 22:65872004.
29	Cai L, Stauder MC, Zhang YJ, et al: Early-stage primary bone lymphoma: a retrospective, multicenter rare cancer network (RCN) study. Int J Radiat Oncol Biol Phys. 83:284–291. 2012. View Article : Google Scholar : PubMed/NCBI
30	Barbieri E, Cammelli S, Mauro F, et al: Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II. Int J Radiat Oncol Biol Phys. 59:760–764. 2004. View Article : Google Scholar : PubMed/NCBI
31	Zinzani PL, Carrillo G, Ascani S, et al: Primary bone lymphoma: experience with 52 patients. Haematologica. 88:280–285. 2003.PubMed/NCBI
32	Catlett JP, Williams SA, O'Connor SC, Krishnan J and Malkovska V: Primary lymphoma of bone: an institutional experience. Leuk Lymphoma. 49:2125–2132. 2008. View Article : Google Scholar : PubMed/NCBI
33	Alencar A, Pitcher D, Byrne G and Lossos IS: Primary bone lymphoma - the university of miami experience. Leuk Lymphoma. 51:39–49. 2010. View Article : Google Scholar : PubMed/NCBI
34	Pellegrini C, Gandolfi L, Quirini F, et al: Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients. Clin Lymphoma Myeloma Leuk. 11:321–325. 2011. View Article : Google Scholar : PubMed/NCBI
35	Horning SJ, Weller E, Kim K, et al: Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern cooperative oncology group study 1484. J Clin Oncol. 22:3032–3038. 2004. View Article : Google Scholar : PubMed/NCBI
36	Messina C, Ferreri AJ, Govi S, et al: International Extranodal Lymphoma Study Group (I.E.L.S.G.): Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study). Br J Haematol. 164:834–840. 2014. View Article : Google Scholar : PubMed/NCBI
37	Gutierrez-Garcia G, Colomo L, Villamor N, et al: Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma. 51:1225–1232. 2010. View Article : Google Scholar : PubMed/NCBI
38	Rieger M, Osterborg A, Pettengell R, et al: MabThera International Trial (MInT) Group: Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol. 22:664–670. 2011. View Article : Google Scholar : PubMed/NCBI
39	Feugier P, Van Hoof A, Sebban C, et al: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 23:4117–4126. 2005. View Article : Google Scholar : PubMed/NCBI
40	Pfreundschuh M, Trumper L, Osterborg A, et al: MabThera International Trial Group: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera international trial (MInT) group. Lancet Oncol. 7:379–391. 2006. View Article : Google Scholar : PubMed/NCBI
41	Sehn LH, Donaldson J, Chhanabhai M, et al: Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 23:5027–5033. 2005. View Article : Google Scholar : PubMed/NCBI
42	Qian L, Zhang Z, Shen J and Liu Y: Primary bone marrow B-cell non-Hodgkin's lymphoma successfully treated with R-CHOP. West Indian Med J. 62:89–91. 2013.PubMed/NCBI
43	Shivakumar L and Armitage JO: Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma. Clin Lymphoma Myeloma. 6:455–457. 2006. View Article : Google Scholar : PubMed/NCBI
44	Mounier N, Briere J, Gisselbrecht C, et al: Groupe d'Etude des Lymphomes de l'Adulte: Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma. Haematologica. 91:715–716. 2006.PubMed/NCBI
45	Winter JN, Weller EA, Horning SJ, et al: Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood. 107:4207–4213. 2006. View Article : Google Scholar : PubMed/NCBI
46	Nyman H, Adde M, Karjalainen-Lindsberg ML, et al: Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood. 109:4930–4935. 2007. View Article : Google Scholar : PubMed/NCBI
47	Rigacci L, Scoccianti G, Puccini B, et al: Primary lymphoma of bone: single center experience. Drugs Cell Ther Hematol. 2:147–156. 2013. View Article : Google Scholar
48	Ostrowski ML, Unni KK, Banks PM, et al: Malignant lymphoma of bone. Cancer. 58:2646–2655. 1986. View Article : Google Scholar : PubMed/NCBI
49	Fidias P, Spiro I, Sobczak ML, et al: Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys. 45:1213–1218. 1999. View Article : Google Scholar : PubMed/NCBI
50	Horsman JM, Thomas J, Hough R and Hancock BW: Primary bone lymphoma: a retrospective analysis. Int J Oncol. 28:1571–1575. 2006.PubMed/NCBI
51	Jawad MU, Schneiderbauer MM, Min ES, et al: Primary lymphoma of bone in adult patients. Cancer. 116:871–879. 2010. View Article : Google Scholar : PubMed/NCBI
52	Stein ME, Kuten A, Gez E, et al: Primary lymphoma of bone - a retrospective study. Experience at the Northern Israel Oncology Center (1979–2000). Oncology. 64:322–327. 2003. View Article : Google Scholar : PubMed/NCBI
53	Govi S, Christie D, Messina C, et al: International Extranodal Lymphoma Study Group (I.E.L.S.G.): The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone. Ann Oncol. 25:176–181. 2014. View Article : Google Scholar : PubMed/NCBI
54	Kim SY, Shin DY, Lee SS, et al: Clinical characteristics and outcomes of primary bone lymphoma in Korea. Korean J Hematol. 47:213–218. 2012. View Article : Google Scholar : PubMed/NCBI
55	Matikas A, Briasoulis A, Tzannou I, et al: Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center. Acta Haematol. 130:291–296. 2013. View Article : Google Scholar : PubMed/NCBI
56	Maruyama D, Watanabe T, Beppu Y, et al: Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study. Jpn J Clin Oncol. 37:216–223. 2007. View Article : Google Scholar : PubMed/NCBI
57	Liu YC, Gau JP, Yu YB, et al: Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 years. Intern Med. 53:95–101. 2014. View Article : Google Scholar : PubMed/NCBI
58	Marshall DT, Amdur RJ, Scarborough MT, et al: Stage IE primary non-Hodgkin's lymphoma of bone. Clin Orthop Relat Marshall Res. 405:216–222. 2002. View Article : Google Scholar
59	Christie D, Dear K, Le T, et al: Limited chemotherapy and shrinking field radiotherapy for osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trial. Int J Radiat Oncol Biol Phys. 80:1164–1170. 2011. View Article : Google Scholar : PubMed/NCBI
60	Lowry L, Smith P, Qian W, et al: Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol. 100:86–92. 2011. View Article : Google Scholar : PubMed/NCBI
61	Scoccianti G, Rigacci L, Puccini B, et al: Primary lymphoma of bone: outcome and role of surgery. Int Orthop. 37:2437–2442. 2013. View Article : Google Scholar : PubMed/NCBI